{"id":"W4379600190","doi":"10.1093/bjd/ljad182","title":"Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Probity Medical Research; Calgary Laboratory Services; SKiN Health","funders":"","keywords":"Scalp; Tolerability; Roflumilast; Medicine; Psoriasis; Randomized controlled trial; Clinical endpoint; Adverse effect; Randomization; Dermatology; Surgery; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001197346,0.0003311599,0.002266095,0.0004595243,0.0004295536,0.0000862042,0.0003265104,0.0003866617,0.00008558742],"category_scores_gemma":[0.0004390006,0.0003066783,0.0006218095,0.000287146,0.0003016995,0.0002264851,0.00008677015,0.0003513159,0.0000882437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003109815,"about_ca_system_score_gemma":0.0001686005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005939616,"about_ca_topic_score_gemma":0.0000853771,"domain_scores_codex":[0.9964551,0.001030141,0.001397891,0.0003830449,0.0001000541,0.0006337468],"domain_scores_gemma":[0.9971852,0.001442609,0.0007466495,0.0001985342,0.0003251462,0.0001018369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.905835,0.002544822,0.003039778,0.00005924967,0.00710226,0.003595413,0.001094639,0.000003340398,0.005227435,0.0001782873,0.01362922,0.05769061],"study_design_scores_gemma":[0.9659086,0.000859902,0.0009105184,0.000101386,0.002088301,0.02264149,0.001175379,0.00003027925,0.003208992,0.000267186,0.002512685,0.0002952671],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9764458,0.01793833,0.000219081,0.0007492943,0.001950704,0.002410079,0.00007147883,0.0000795418,0.0001356703],"genre_scores_gemma":[0.996322,0.002064803,0.00007780895,0.00009947475,0.0001922193,0.0004726298,0.00006996711,0.00004256438,0.0006585739],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06007366,"threshold_uncertainty_score":0.9999385,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02527273897059209,"score_gpt":0.2932965594720684,"score_spread":0.2680238205014763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}